title: [Two-year results after implantation of a metallic stent EPHESOS in patients with coronary heart disease].
abstract: OBJECTIVE
  To evaluate two-year results of using a metallic stent EPHESOS in patients with native atherosclerotic lesion of coronary arteries (without prior interventions).
  
  
  METHODS
  The stent was implanted to 731 patients. 53% had manifestations of unstable angina. 42% of the lesions were complicated. The length of the stenosis was 15.5 +/- 6.8 mm, 44% stenoses were long.
  
  
  RESULTS
  The success of stenting was 99.6%. Cases of acute and subacute thrombosis were absent. Non-Q wave myocardial infarction in primary hospitalization developed in 4 patients. For 6 months, cardiovascular complications (death, angina, restenosis, repeated revascularization) occurred in 21%. Angiographic control follow-up of 6 months maximum covered 329 (45%) patients. Hemodynamically significant restenosis was detected in 18% patients. Cardiovascular complications for 24 months occurred in 39%.
  
  
  CONCLUSIONS
  The EPHESOS stent has demonstrated a stable long-term effect on prevention of thrombosis and restenosis in the majority of patients with a relatively high risk of intervention.
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Belenkov
authors.forename: A N
authors.initials: AN
authors.lastname: Samko
authors.forename: T A
authors.initials: TA
authors.lastname: Batyraliev
authors.forename: I V
authors.initials: IV
authors.lastname: Pershukov
authors.forename: Z A
authors.initials: ZA
authors.lastname: Niiazova-Karben
authors.forename: F
authors.initials: F
authors.lastname: Besnili
authors.forename: I V
authors.initials: IV
authors.lastname: Levitskiĭ
authors.forename: Sh T
authors.initials: ShT
authors.lastname: Zhamgyrchiev
authors.forename: A
authors.initials: A
authors.lastname: Vural
authors.forename: O
authors.initials: O
authors.lastname: Kalenich
mesh_terms: D003327:Coronary Disease / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome